McMaster University

Heather Mason-Wood appointed as President and Chief Strategy Officer of Canso Investment Counsel

Retrieved on: 
Wednesday, March 8, 2023

RICHMOND HILL, ON, March 8, 2023 /CNW/ - John Carswell, CEO of Canso Investment Counsel Ltd., is pleased to announce the appointment of Heather Mason-Wood as President and Chief Strategy Officer of the company.

Key Points: 
  • RICHMOND HILL, ON, March 8, 2023 /CNW/ - John Carswell, CEO of Canso Investment Counsel Ltd., is pleased to announce the appointment of Heather Mason-Wood as President and Chief Strategy Officer of the company.
  • Mason-Wood, CFA, who joined Canso in 2003, will continue to be a Portfolio Manager and, as one of its most experienced and respected credit professionals, will continue to report to Carswell in his capacity as Chief Investment Officer.
  • "With more than 20 years of leadership at Canso, Heather has been instrumental in the successful growth of Canso from a team of 5 people to the nearly 60 people we have today.
  • Before her appointment as President and Chief Strategy Officer, Mason-Wood served as Canso's Chief Strategy and Operating Officer.

ReSuture, Inc. Awarded $996,413 NSF Phase II Small Business Innovation Research Grant to Support Surgical Performance and Medical Device Development

Retrieved on: 
Monday, March 6, 2023

The grant will support commercialization of ReSuture's products and technology to evaluate vascular surgical operative performance in both open and endovascular fields.

Key Points: 
  • The grant will support commercialization of ReSuture's products and technology to evaluate vascular surgical operative performance in both open and endovascular fields.
  • The grant, entitled "SBIR Phase II: Quantification of Operative performance through Simulated Surgical Platforms, Capacitive Sensing, and Machine Learning to Improve Surgeon Performance and Medical Device Development," will be conducted in conjunction with Arizona State University (ASU).
  • Gore, Teleflex Medical, Becton Dickinson, Endologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic.
  • This NSF Phase II funding represents a tremendous opportunity for further development and commercial scaling of our products that can improve surgical training and revolutionize development pipelines in the medical device industry.

Government of Canada establishes a new research hub at the University of Ottawa to accelerate Canada's vaccine and therapeutics production

Retrieved on: 
Monday, March 6, 2023

The Canadian Pandemic Preparedness Hub is being led by the University of Ottawa and McMaster University.

Key Points: 
  • The Canadian Pandemic Preparedness Hub is being led by the University of Ottawa and McMaster University.
  • It will catalyze research and biomanufacturing innovations to help Canada produce vaccines, therapeutics and diagnostics ahead of future pandemics.
  • This multidisciplinary research hub will accelerate research and development of next-generation vaccines, therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent.
  • Biosciences Research Infrastructure Fund: $500 million to support the biosciences infrastructure needs of postsecondary institutions and affiliated research hospitals.

Government of Canada establishes new research hubs to accelerate Canada's vaccine and therapeutics production

Retrieved on: 
Thursday, March 2, 2023

The multidisciplinary research hubs will accelerate the research and development of next-generation vaccines and therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent.

Key Points: 
  • The multidisciplinary research hubs will accelerate the research and development of next-generation vaccines and therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent.
  • The hubs will also accelerate the translation of promising research into commercially viable products and processes.
  • The research hubs announced today are critical in our national quest to establish a strong Canadian presence in the bioindustry sector and, particularly, domestic vaccine production.
  • Whether between research teams, across disciplines, or among institutions and industry sectors, the Biosciences Research Infrastructure Fund complements the efforts of the research hubs.

AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario

Retrieved on: 
Wednesday, March 1, 2023

TORONTO, March 1, 2023 /PRNewswire/ - AtomVie Global Radiopharma Inc. ( AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility.

Key Points: 
  • TORONTO, March 1, 2023 /PRNewswire/ - AtomVie Global Radiopharma Inc. ( AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility.
  • Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organization (CDMO) facility that is home for more than 10 international radiopharmaceutical GMP manufacturing programs.
  • AtomVie is well positioned to solidify and grow its presence as a global leader in radiopharmaceutical GMP manufacturing, serving patients locally and worldwide.
  • "AtomVie celebrates yet another milestone by beginning a buildout that will increase our capacity more than ten-fold" says Bruno Paquin, CEO of AtomVie Global Radiopharma.

AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario

Retrieved on: 
Wednesday, March 1, 2023

TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ( AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility.

Key Points: 
  • TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ( AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility.
  • Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organization (CDMO) facility that is home for more than 10 international radiopharmaceutical GMP manufacturing programs.
  • AtomVie is well positioned to solidify and grow its presence as a global leader in radiopharmaceutical GMP manufacturing, serving patients locally and worldwide.
  • "AtomVie celebrates yet another milestone by beginning a buildout that will increase our capacity more than ten-fold" says Bruno Paquin, CEO of AtomVie Global Radiopharma.

MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results

Retrieved on: 
Tuesday, February 28, 2023

MARIETTA, Ga., Feb. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced operating and financial results for the fourth quarter and full year 2022.

Key Points: 
  • Segment results for the year ended December 31, 2022 and 2021 can be found at the end of this press release.
  • For the full year 2022, MIMEDX reported net sales of $267.8 million, compared to $258.6 million in the prior year period, reflecting growth of 3.6%.
  • SG&A expense during the fourth quarter 2022 included increased sales commissions and the impact of severance associated with restructuring activities.
  • MIMEDX will host a conference call and webcast to review its fourth quarter and full year 2022 results on Tuesday, February 28, 2023, beginning at 5:00 p.m., Eastern Time.

Masco Corporation Announces Executive Appointments

Retrieved on: 
Monday, February 27, 2023

Most recently, Mr. Shah held the position of Group President-Decorative Architectural Products, a position he assumed in 2018.

Key Points: 
  • Most recently, Mr. Shah held the position of Group President-Decorative Architectural Products, a position he assumed in 2018.
  • He joined Masco in 2003 and has held a variety of leadership roles in finance, human resources, corporate strategy and group operations.
  • Imran Ahmad, currently President of Masco Canada, has been promoted to Group President-Decorative Architectural Products.
  • Both Jai and Imran have made significant contributions to our organization over the years, and I am confident that they will provide strong thought leadership and strategic direction for our business and have a positive and immediate impact,” said Keith Allman, President and Chief Executive Officer of Masco Corporation.

Pathways to Education Canada appoints Tracey Taylor-O'Reilly as new President & CEO

Retrieved on: 
Monday, February 27, 2023

TORONTO, Feb. 27, 2023 /CNW/ - Pathways to Education Canada, a national charitable organization supporting students in low-income communities to graduate from high school, is pleased to announce the appointment of Tracey Taylor-O'Reilly as President and Chief Executive Officer.

Key Points: 
  • TORONTO, Feb. 27, 2023 /CNW/ - Pathways to Education Canada, a national charitable organization supporting students in low-income communities to graduate from high school, is pleased to announce the appointment of Tracey Taylor-O'Reilly as President and Chief Executive Officer.
  • Prior to joining York University, Tracey held leadership and teaching positions at McMaster University and currently serves as a Board member for Achēv.
  • Tracey has been recognized for her leadership through a number of awards—in 2021 she was honoured with the WXN Top 100 Most Powerful Women in Canada award.
  • "We are absolutely thrilled to welcome Tracey to the organization," says Vince Mercier, Chair of Pathways to Education's Board of Directors.

McMaster University Develops Novel Experimental Designs with ZEISS LaserFIB and Next-Generation 3D X-ray Microscope

Retrieved on: 
Wednesday, February 22, 2023

WHITE PLAINS, N.Y. and HAMILTON, ON, Feb. 22, 2023 /PRNewswire/ -- The Canadian Centre for Electron Microscopy (CCEM), located at McMaster University, recently acquired a ZEISS Crossbeam 350 laser FIB-SEM and a next-generation Versa 3D X-ray microscope. This opens new innovative approaches to science by correlating high-resolution non-destructive 3D X-ray imaging with FIB-SEM 3D imaging aided by integrated femtosecond laser for precise machining. This enables high-resolution 2D and 3D analysis at sites within millimeter volumes of materials.   

Key Points: 
  • WHITE PLAINS, N.Y. and HAMILTON, ON, Feb. 22, 2023 /PRNewswire/ -- The Canadian Centre for Electron Microscopy (CCEM), located at McMaster University, recently acquired a ZEISS Crossbeam 350 laser FIB-SEM and a next-generation Versa 3D X-ray microscope.
  • This opens new innovative approaches to science by correlating high-resolution non-destructive 3D X-ray imaging with FIB-SEM 3D imaging aided by integrated femtosecond laser for precise machining.
  • This enables high-resolution 2D and 3D analysis at sites within millimeter volumes of materials.
  • These advancements will be demonstrated in an upcoming free workshop March 6-7 scheduled as a hybrid event with international speakers.